Seth M. Steinberg

Generating author description...

All published works

Action	Title	Year	Authors
+	Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs).	2023	Meredith J. McAdams Shannon Swift Renee N. Donahue Carolina Celades Yo-Ting Tsai Molly A. Bingham Éva Szabó Chen Zhao Susan Sansone Nirmal Choradia
+	Systematic review of pediatric oncology phase I trials: Toxicity and outcomes in the era of targeted therapies.	2018	Julia Wanda Cohen Srivandana Akshintala Eli Kane Seth M. Steinberg Brigitte C. Widemann Nirali N. Shah
+	Quantile Estimation	2014	C.E. Davis Seth M. Steinberg
+ PDF Chat	The statistics of phase 0 trials	2010	Larry Rubinstein Seth M. Steinberg Shivaani Kummar Robert J. Kinders Ralph E. Parchment Anthony J. Murgo Joseph E. Tomaszewski James H. Doroshow
+ PDF Chat	Designing Phase 0 Cancer Clinical Trials	2008	Anthony J. Murgo Shivaani Kummar Larry Rubinstein Martin Gutierrez Jerry M. Collins Robert J. Kinders Ralph E. Parchment Jiuping Ji Seth M. Steinberg Sherry X. Yang
+	Phase 0 Clinical Trials in Cancer Drug Development: From FDA Guidance to Clinical Practice	2007	Robert J. Kinders Ralph E. Parchment Jung Hwan Ji Shivaani Kummar Anthony J. Murgo Martin Gutierrez Jerry M. Collins Larry Rubinstein Oxana K. Pickeral Seth M. Steinberg
+	Compressing drug development timelines in oncology using phase '0' trials	2007	Shivaani Kummar Robert J. Kinders Larry Rubinstein Ralph E. Parchment Anthony J. Murgo Jerry M. Collins Oxana K. Pickeral Jennifer A. Low Seth M. Steinberg Martin Gutierrez
+	Quantile Estimation	2005	C.E. Davis Seth M. Steinberg
+	Early selection in a randomized phase II clinical trial	2002	Seth M. Steinberg David Venzon
+	Comparison of nonparametric point estimators for interquantile differences in moderate sized samples	1987	Seth M. Steinberg C.E. Davis
+	Distribution-free confidence intervals for quantiles in small samples	1985	Seth M. Steinberg C.E. Davis
+	Confidence intervals for functions of quantiles using linear combinations of order statistics	1983	Seth M. Steinberg

Common Coauthors

Coauthor	Papers Together
Larry Rubinstein	4
Ralph E. Parchment	4
Robert J. Kinders	4
Shivaani Kummar	4
C.E. Davis	4
Anthony J. Murgo	4
Lee J. Helman	3
James H. Doroshow	3
Joseph E. Tomaszewski	3
Robert H. Wiltrout	3
Sherry X. Yang	3
Jerry M. Collins	3
Martin Gutierrez	2
Oxana K. Pickeral	2
Melinda G. Hollingshead	2
Renee N. Donahue	1
Julia W. Cohen	1
Nirmal Choradia	1
Meenakshi Shelat	1
Meredith J. McAdams	1
Jennifer A. Low	1
Susan Sansone	1
James L. Gulley	1
Brigitte C. Widemann	1
Eli Kane	1
Tyler D. Ames	1
Carolina Celades	1
Arun Rajan	1
Melanie A. Simpson	1
Alice Chen	1
J E Tomaszewski	1
J. H. Doroshow	1
Jeffrey Schlom	1
Chen Zhao	1
Shannon Swift	1
Éva Szabó	1
Jiuping Ji	1
Martin Gutierrez	1
David Venzon	1
Jung Hwan Ji	1
Srivandana Akshintala	1
Nirali N. Shah	1
Yo-Ting Tsai	1
Molly A. Bingham	1
Joseph Francis O'Donnell	1
Brooke Raphael	1
Alice Chen	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	A generalized quantile estimator	1982	W.D. Kalgh Peter A. Lachenbruch	5
+	Quantile interval estimation	1983	W. D. Kaigh	4
+	A new distribution-free quantile estimator	1982	Frank E. Harrell C.E. Davis	4
+	Compressing drug development timelines in oncology using phase '0' trials	2007	Shivaani Kummar Robert J. Kinders Larry Rubinstein Ralph E. Parchment Anthony J. Murgo Jerry M. Collins Oxana K. Pickeral Jennifer A. Low Seth M. Steinberg Martin Gutierrez	3
+	Distribution-Free Confidence Intervals for Quantile Intervals	1976	Daniel Krewski	2
+	Censored Data and the Bootstrap	1981	Bradley Efron	2
+ PDF Chat	Non-Parametric Estimation. I. Validation of Order Statistics	1945	Henry Scheffé John W. Tukey	2
+	Quantile estimators of Johnson curve parameters	1980	Robert E. Wheeler	2
+	Phase 0 Clinical Trials in Cancer Drug Development: From FDA Guidance to Clinical Practice	2007	Robert J. Kinders Ralph E. Parchment Jung Hwan Ji Shivaani Kummar Anthony J. Murgo Martin Gutierrez Jerry M. Collins Larry Rubinstein Oxana K. Pickeral Seth M. Steinberg	2
+ PDF Chat	Minimally Invasive Pharmacokinetic and Pharmacodynamic Technologies in Hypothesis-Testing Clinical Trials of Innovative Therapies	2006	Paul Workman Eric O. Aboagye Yuen‐Li Chung John R. Griffiths Rachel Hart Martin O. Leach Ross J. Maxwell Paul M.J. McSheehy Pat Price Jamal Zweit	2
+	Simplified Efficient Point and Interval Estimators for Weibull Parameters	1975	Nancy R. Mann Kenneth W. Fertig	2
+	Estimation of Quantiles of Exponential Distributions with Minimum Error in Predicted Distribution Functions	1977	Craig Robertson	2
+	Common content of a regular hypersimplex and a concentric hypersphere	1981	M. Masoom Ali J. G. C. Templeton	2
+	Estimation of Weibull Quantiles With Minimum Error in the Distribution Function	1979	Ray E. Schafer John E. Angus	2
+	Estimating a Quantile of an Exponential Distribution	1982	Andrew L. Rukhin William E. Strawderman	2
+	Estimation of the parameters and quantiles of the logistic distribution by linear functions of sample quantiles	1981	R. L. Eubank	2
+	A Survey of Properties and Applications of the Noncentral t-Distribution	1968	D. B. Owen	2
+	Efficient Unbiased Quantile Estimators for Moderate-Size Complete Samples from Extreme-Value and Weibull Distributions; Confidence Bounds and Tolerance and Prediction Intervals	1977	Nancy R. Mann Kenneth W. Fertig	2
+	Construction of Tolerance Bounds for the Extreme-Value and Weibull Distributions	1975	Jerald F. Lawless	2
+	On inference for a mixture of a poisson and a degenerate distribution	1981	Dale Umbach	2
+ PDF Chat	Optimal two-stage designs for phase II clinical trials	1989	Richard Simon	2
+ PDF Chat	On Confidence Ranges for the Median and Other Expectation Distributions for Populations of Unknown Distribution Form	1936	William Thompson	2
+	Quantile estimation from grouped data: the cell midpoint	1977	Bruce W. Schmeiser Stuart Jay Deutsch	2
+ PDF Chat	Bootstrap Methods: Another Look at the Jackknife	1979	B. Efron	2
+	Estimation of quantiles of exponential and double exponential distributions based on two order statistics	1981	Masoom Ali Mir Umbach Dale Khatab M. Hassanein	1
+ PDF Chat	Confidence Intervals for a Binomial Parameter Based on Multistage Tests	1987	Diane E. Duffy Thomas J. Santner	1
+	Rethinking clinical trials for cytostatic drugs	2003	Andrew Millar Kevin Lynch	1
+	Regulatory considerations for preclinical development of anticancer drugs	1997	Joseph J. DeGeorge Chang‐Ho Ahn Paul A. Andrews Margaret E. Brower Diana W. Giorgio M. Anwar Goheer Doo Young Lee-Ham W. David McGuinn W Schmidt Chen Sun	1
+ PDF Chat	Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?	2009	Patricia LoRusso	1
+	A Note on Nonlinear Median Estimators	1973	Håkan Ekblom	1
+ PDF Chat	Estimation of the Mean and Standard Deviation by Order Statistics	1954	A. E. Sarhan	1
+	Sample size and power determination for stratified clinical trials	1978	David P. Bernstein Stephen W. Lagakos	1
+	Estimating pareto quantiles using two order statistics	1981	Umbach Dale Masoom Ali Mir Khatab M. Hassanein	1
+	Survey of Properties and Applications of the Noncentral<i>t</i>-Distribution	1968	D. B. Owen	1
+	A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials	1989	Peter F. Thall Richard Simon Susan S. Ellenberg	1
+	Construction of Tolerance Bounds for the Extreme-Value and Weibull Distributions	1975	Jerald F. Lawless	1
+	Estimation of the population median	1969	M. Mahamunulu Desu Robert H. Rodine	1
+ PDF Chat	The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials	2007	Silvia Marchetti Jan H.M. Schellens	1
+ PDF Chat	Leveraging Exploratory Investigational New Drug Studies to Accelerate Drug Development	2008	David Jacobson‐Kram George Q. Mills	1
+	Selecting and Ordering Populations: A New Statistical Methodology	2000	MTW Jean Dickinson Gibbons Ingram Olkin Milton Sobel	1
+ PDF Chat	The Development of Phase I Cancer Trial Methodologies: the Use of Pharmacokinetic and Pharmacodynamic End Points Sets the Scene for Phase 0 Cancer Clinical Trials	2008	A H Calvert Ruth Plummer	1
+ PDF Chat	Phase I Trial Design for Solid Tumor Studies of Targeted, Non-Cytotoxic Agents: Theory and Practice	2004	Wendy R. Parulekar Elizabeth A. Eisenhauer	1
+	Oncologic Phase 0 Trials Incorporating Clinical Pharmacodynamics: from Concept to Patient	2008	James H. Doroshow Ralph E. Parchment	1
+	Phase 0 Trials: An Industry Perspective	2008	Helen Eliopoulos Vincent L. Giranda Robert A. Carr Rita Tiehen Terri Leahy Gary Gordon	1
+ PDF Chat	Design of Phase II Cancer Trials Using a Continuous Endpoint of Change in Tumor Size: Application to a Study of Sorafenib and Erlotinib in Non Small-Cell Lung Cancer	2007	Theodore Karrison Michael L. Maitland Walter M. Stadler Mark J. Ratain	1
+	Nonparametric Statistical Inference	2012		1
+	Nonparametric Confidence Intervals for the Median in the Presence of Right Censoring	1982	John D. Emerson	1
+	Confidence Limits for Probability of Response in Multistage Phase II Clinical Trials	1985	E. Neely Atkinson Barry W. Brown	1
+	Interval Estimation of a Median	1974	Jan Lanke	1
+	Randomized phase II clinical trials.	1985	Richard Simon R. Wittes Susan S. Ellenberg	1